Welcome to PsychU!

Live Event – Strategies to Optimize Patient Outcomes in Bipolar Disorder 1

Loading Events

Live Event – Strategies to Optimize Patient Outcomes in Bipolar Disorder 1

This is a Live Private Event for Healthcare Professionals in Manhattan, Brooklyn, Queens, NY.

Bipolar I Disorder is characterized by mood episode recurrence, which impacts patient functioning and clinical outcomes.1,2 During our discussion, Drs. Erika Modh and Jehan Marino will discuss risk factors for mood recurrence including non-adherence. They will also discuss some management strategies including long acting injectables (LAIs) that may optimize patient outcomes.

Objectives:

  • Understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes
  • Discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder
  • Review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder
  • References:

    1. Vaquez GH European Neuropsychopharmacology 2015; 25: 1501-1512
    2. Kapczinski NS, et al. Expert Rev Neurother. 2017;17(3):277-285

Venue

Fushimi – Williamsburg

475 Driggs Avenue
Williamsburg, New York 11211 United States
+ Google Map
(718) 963-2555 View Venue Website

Featuring

Jehan-Marino

Jehan Marino, PharmD, BCPP (OPDC)

Clinical & Scientific Director

Erika-Modh

Erika Modh, PharmD, BCPS (OPDC)

Clinical & Scientific Liaison

Speakers Jehan Marino, PharmD, BCPP and Erika Modh, PharmD, BCPS are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS

PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.

PSYCHU MEMBERSHIP ELIGIBILITY

In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.

MEMBERSHIP & REGISTRATION

Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.

ATTENDANCE LIMITATIONS

PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.

MEAL REPORTING

The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.